Executive Management

 

Dr Ryan Cawood (Founder & Chief Executive Officer)

Ryan founded Oxford Genetics in 2011 with the aim to revolutionise DNA design, optimisation and assembly to enable molecular engineering to fulfil its promise in synthetic biology and medicine. Ryan has a first class degree in Genetics and a Ph.D. from Oxford University. He is an experienced genetic engineer having developed a range of virus expression systems for both gene therapy and oncolytic applications. Ryan's research interests in synthetic biology and molecular engineering include vaccines and treatments for infectious diseases and cancer, focusing primarily on understanding the complexities of mammalian biology and maximising output for therapeutic applications.

 

Ryan Cawood

 

Dr Paul Brooks (Chief Commercial Officer)

Paul joined Oxford Genetics from Sigma-Aldrich, where he was responsible for the commercialisation of their genome editing technologies and associated services. Over the course of his career he has held various positions in both the USA and Europe focused on functional genomics including strategy, business development, marketing, product management and sales. Paul holds a BSc in biochemistry from the University of Wales, a Ph.D in molecular biology from the University of Manchester, and a MBA from the University of Nottingham.

 

Ryan Cawood

 

Dr Tom Payne (Chief Scientific Officer)

Tom has >10 years commercial experience in biopharmaceutical development and bioproduction, having held R&D and commercially-focused roles at both Novozymes Biopharma (now Albumedix) and Lonza in the UK. At Oxford Genetics, Tom is responsible for technology development activities, spanning the breadth of services and products offered. His research interests include gene editing, synthetic biology and cellular engineering. Tom holds a BSc and Ph.D in Molecular Biology from the University of Nottingham.

 

Ryan Cawood

 

Martin Hall (Chief Financial Officer)

Martin joined Oxford Genetics in November 2017 and has more than 30 years financial and general management experience in technology and IP-focused businesses. He specialises in leading and developing small technology organisations through periods of rapid growth, fund-raising and international expansion to exit events including trade sale or preparation for IPO. Martin’s most recent role was CFO of Warwick-based Allinea Software, culminating in the successful sale of the business with an average return to shareholders of 100 x net investment. Prior experience includes fourteen years as global Head of Finance of Oxfordshire-headquartered Sophos - during which time the business grew from £2 million turnover and 15 employees to over £100 million turnover and 1,100 employees. Martin qualified as a Chartered Accountant with Price Waterhouse in London and holds a MA degree in Economics from the University of Cambridge.

Ryan Cawood